
VYGR EPS Estimates
Voyager Therapeutics, Inc.
$1.65
+$0.02(+0.92%)
42
Overall
60
Value
27
Tech
39
Quality
Market Cap
$102.37M
Volume
375.85K
52W Range
$1.59 - $5.48
Target Price
$15.38
VYGR EPS estimates: the consensus estimate for Voyager Therapeutics, Inc.'s current fiscal year is -$1.60 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
VYGR EPS Estimates
- EPS estimate, current quarter
- $-0.34
- EPS estimate, next quarter
- $-0.31
- EPS estimate, current year
- $-1.60
- EPS estimate, next year
- $-1.28
- EPS growth, 3-year
- -19.02%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.04 |
| 2024 | $-1.13 |
| 2023 | $3.08 |
| 2022 | $-1.21 |
| 2021 | $-1.89 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VYGR | $1.65 | +0.9% | 375.85K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Voyager Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW